---

Hyperventilation and Hypoventilation During Anesthesia

PART I: PHYSIOLOGY - THE FOUNDATION

Alveolar Ventilation and PaCO₂

PaCO₂ = k × VCO₂ / VA (where k = 0.86)

• Doubling VA halves PaCO₂ (hyperventilation)
• Halving VA doubles PaCO₂ (hypoventilation)

Normal Values (for reference)

---

PART II: HYPOVENTILATION DURING ANESTHESIA

Definition

Mechanisms and Causes

1. Anesthetic Drug Effects on Respiratory Drive

• Volatile anesthetics depress both central and peripheral chemoreceptors
• At even 0.1 MAC, isoflurane and sevoflurane abolish the peripheral (carotid body) CO₂ chemoreflex
• Above 1 MAC, the peripheral chemoreflex is completely lost; only central chemoreflex remains
• In conscious humans, minute ventilation increases ~3 L/min per 1 mmHg rise in PaCO₂; this response is profoundly attenuated by volatile anesthetics
• Apneic threshold: The minimum PaCO₂ below which spontaneous ventilation ceases. It is normally 4-5 mmHg below the resting PaCO₂. Volatile anesthetics cause a rightward shift of this threshold - meaning spontaneous breathing efforts will not occur if controlled ventilation drives PaCO₂ below this shifted threshold (Barash, p. 1433)

Clinical Pearl: Assisting ventilation in a spontaneously breathing anesthetized patient may lower PaCO₂ to the apneic threshold, causing apnea and necessitating full controlled ventilation.

• Cause respiratory depression through μ-receptor agonism in brainstem respiratory centers
• Decrease respiratory rate more than tidal volume (opposite of volatile agents)
• Diminish the CO₂ response curve (shift rightward AND decrease slope)
• Hypoxic ventilatory response abolished even at subanesthetic doses
• Synergistic respiratory depression when combined with volatile agents

• Propofol produces dose-dependent respiratory depression and apnea on induction
• Benzodiazepines depress ventilatory response to CO₂; synergistic with opioids

2. Neuromuscular Blockade (NMB)

• Incomplete reversal of NMB impairs the pressure-generating capacity of respiratory muscles
• According to the equation of motion: Pmus = V × R + V × E - reduced Pmus yields reduced tidal volume
• Decrements in Pmus initially trigger compensatory increases in rate, but hypercapnia develops when compensation is exhausted (Miller's Anesthesia, p. 1300)
• Upper airway muscle weakness is more sensitive to residual NMB than diaphragmatic weakness, predisposing to obstruction

3. Airway Obstruction

4. Increased Dead Space

• Pulmonary embolism (most acute increase in dead space)
• Emphysema (chronic)
• Rapid shallow breathing pattern (increases VD/VT ratio)
• Mechanical ventilator circuit and HME filters add instrumental dead space

5. Increased CO₂ Production (Relative Hypoventilation)

• Malignant hyperthermia - massive uncontrolled increase in metabolic rate; early sign is rising ETCO₂
• Thyroid storm, sepsis, fever, shivering
• Laparoscopic surgery - absorption of insufflated CO₂ from peritoneum (planned increase in ventilation required)
• High-carbohydrate TPN while on controlled ventilation

6. Altered Respiratory Mechanics

• Pneumothorax, hemothorax, pleural effusion
• Abdominal distension, prone positioning, obesity (reduced FRC, increased atelectasis)
• Pulmonary edema reducing compliance
• Bronchospasm increasing resistance

Consequences of Hypoventilation / Hypercapnia

Management

1. Identify the cause - check ETT position, circuit integrity, capnograph waveform
2. Controlled ventilation - if spontaneous breathing is inadequate
3. Reverse residual NMB - neostigmine + glycopyrrolate or sugammadex
4. Reverse opioids if appropriate - naloxone (titrate to avoid acute pain/hypertension)
5. Treat bronchospasm - bronchodilators, deepen anesthesia
6. Laparoscopy - increase minute ventilation to compensate for CO₂ absorption (typically increase RR or VT by 10-20%)
7. Postoperatively - supplemental O₂, positioning (head-up), early extubation criteria assessment

---

PART III: HYPERVENTILATION DURING ANESTHESIA

Definition

Causes

1. Iatrogenic (Most Common)

• Excessive mechanical ventilation settings during controlled ventilation
• Aggressive manual bag-mask ventilation during induction
• Over-zealous IPPV in response to perceived inadequacy

2. Neurogenic / Pain-Related

• Anxiety and pain before induction
• Light anesthesia / inadequate depth during surgical stimulation
• CNS stimulation (limbic system activation)

3. Metabolic Compensation

• Pre-existing metabolic acidosis - body attempts to compensate by blowing off CO₂
• Diabetic ketoacidosis, sepsis

4. Physiological Stimuli

• Hypoxia stimulates peripheral chemoreceptors → hyperventilation (though hypoxic ventilatory response is blunted by volatile agents)
• Pulmonary embolism - reflex hyperventilation before hypercapnia supervenes

5. Laparoscopy (Intraabdominal CO₂) - Patient

• Peritoneal stretch and diaphragmatic irritation can stimulate breathing in lightly anesthetized patients

Consequences of Hyperventilation / Hypocapnia

Therapeutic Uses of Controlled Hyperventilation

1. Raised Intracranial Pressure (ICP)

• Mechanism: CO₂ is a potent cerebral vasodilator. Hypocapnia causes cerebral arteriolar vasoconstriction → reduced CBV → reduced ICP
• CO₂ vasoreactivity is preserved under volatile anesthesia (isoflurane, sevoflurane, desflurane up to 1.5 MAC)
• Isoflurane-induced ICP rises can be blunted by hyperventilation
• Limitation: Not a definitive treatment; effect wanes over 6-8 hours (CSF pH equilibrates); extreme hypocapnia (<20 mmHg) can cause ischemia
• Desflurane: Vasoconstrictive response to hypocapnia is preserved - hyperventilation can prevent desflurane-induced ICP rises (Goodman & Gilman)
• Barash (p. 1415): "all three potent agents may be used at appropriate doses, especially with adjunctive and compensatory therapies, in nearly any neurosurgical procedure"

2. Pulmonary Hypertension / Right-to-Left Shunt

• Hyperventilation with hypocapnia reduces PVR
• Combined with 100% O₂, very effective in managing acute pulmonary hypertension intraoperatively

3. Malignant Hyperthermia (initial management)

• Hyperventilate with 100% O₂ to blow off accumulated CO₂ while dantrolene is drawn up

Risks of Therapeutic Hyperventilation

1. Cerebral ischemia - PaCO₂ <20 mmHg can cause paradoxical cerebral vasoconstriction severe enough to produce focal ischemia
2. Carotid endarterectomy - eucapnia preferred because hyperventilation causes vasoconstriction that may further reduce flow to an already ischemic hemisphere
3. Obstetrics - fetal compromise from reduced uterine blood flow
4. Cardiovascular - decreased venous return and cardiac output from high intrathoracic pressures with aggressive positive pressure ventilation

---

PART IV: APNEIC THRESHOLD - A CRITICAL CONCEPT

• Volatile anesthetics cause a rightward shift of the apneic threshold - i.e., a higher PaCO₂ is needed to trigger breathing
• It is independent of the slope of the CO₂ response curve
• Clinical implication: If you assist/augment ventilation in a spontaneously breathing anesthetized patient and reduce PaCO₂ toward or below the apneic threshold, the patient becomes apneic, requiring full controlled ventilation
• N₂O added to a volatile anesthetic lessens this shift (Barash p. 1433)

---

PART V: MONITORING

---

PART VI: SUMMARY TABLE FOR EXAM

---

REFERENCES

• Miller's Anesthesia, 10e - Mechanisms of Hypoxemia and Hypercapnia; Effects of Inhaled Anesthetics on Hypercapnic Ventilatory Response (pp. 1287-1301, 2135-2137)
• Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e - Response to Carbon Dioxide and Hypoxemia; Intracerebral Pressure (pp. 1433-1435, 1415)
• Katzung's Basic and Clinical Pharmacology, 16e - Respiratory Effects of Volatile Anesthetics (p. 702)
• Goodman & Gilman's The Pharmacological Basis of Therapeutics - Desflurane: vasoconstrictive response to hypocapnia
• Morgan & Mikhail's Clinical Anesthesiology, 7e - MAC/Oxygen supplementation; Key Concepts on PVR management